BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Pardes Biosciences Presents Interim Clinical Data from Ongoing PBI-0451 Phase 1 Trial Supporting the Potential of PBI-0451 as a Stand-Alone Oral Regimen for COVID-19 at Conference on Retroviruses and Opportunistic Infections 2022

  Pardes Biosciences, Inc. announced that interim clinical data from its ongoing PBI-0451 Phase 1 trial in healthy adult volunteers has been made available to registered conference attendees at the 29th Conference on Retroviruses and Opportunistic Infections (CROI) 2022.

  February 14, 2022

   · 

  6 min read
• Business

  Mirati Therapeutics to Report Fourth Quarter and Full Year Financial Results for 2021 and Recent Corporate Updates on February 28, 2022

  Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will announce financial results for the fourth quarter and full year of 2021 along with recent corporate updates on February 28, 2022.

  February 14, 2022

   · 

  3 min read
• BioCapital

  MaxCyte to Participate in Upcoming Investor Conferences - Feb 14, 2022

  MaxCyte, Inc. announced Company management will participate in the following virtual investor conferences.

  February 14, 2022

   · 

  2 min read
• Business

  MIMEDX to Host Fourth Quarter 2021 Operating and Financial Results Conference Call on February 28

  MiMedx Group, Inc., a transformational placental biologics company, announced that it will report operating and financial results for the fourth quarter ended December 31, 2021 after the market close on Monday, February 28, 2022.

  February 14, 2022

   · 

  1 min read
• Pharm Country

  Teclison Completes $5.9 Million Capital Raise

  Teclison, a clinical-stage biotechnology company developing innovative cancer therapeutics to induce tumor necrosis and enhance anti-tumor immunity, announced the completion of a $5.9 million in gross proceeds capital raise.

  February 14, 2022

   · 

  2 min read
• Business

  Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements

  Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2021.

  February 14, 2022

   · 

  3 min read
• Medical Device Complaint Management Market is Expected to Garner A Market Value of US$ Bn 10.52 Bn By 2032

  Fact.MR – A Market Research and Competitive Intelligence Provider: The medical device complaint management market has provided a market value of 5.35 bn in 2022.

  February 14, 2022

   · 

  7 min read
• Global Sales of Endoscopes to Accumulate a Market Value of US$ 34 Bn by 2032

  Fact.MR – A Market Research and Competitive Intelligence Provider: The demand for endoscopes has climbed up the market size of endoscope market to 9% CAGR in 2021.

  February 14, 2022

   · 

  6 min read
• Scoliosis Management Market: North America is anticipated to lead the global market

  Scoliosis is a condition that causes an anomalous bend of the spine or spine. It is generally analyzed in early youth or in adolescence.

  February 14, 2022

   · 

  5 min read
• Prefilled Safety Devices Market: Rising Awareness about Prefilled Safety Devices is Projected to Be a Key Driver of the Growth of the Market

  Prefilled safety devices are devices developed as a result of the advancement of innovation in the conventional type of syringes, wherein the needles are created with safety system to anticipate any needle stick or some other needle-related wounds.

  February 14, 2022

   · 

  5 min read